Publications by authors named "A Kureishi"
Article Synopsis
- This study addresses the challenge of differentiating primary central nervous system lymphomas (PCNSLs) from gliomas on MRI, highlighting the need for accurate diagnoses for effective treatment.
- MRI scans from 240 patients were analyzed using an automated workflow involving a pre-trained segmentation network, resulting in high segmentation accuracy for both tumor types.
- Three classification models showed strong performance, particularly the first model that identified PCNSLs from gliomas with an AUC of 0.99, suggesting potential for an automated virtual biopsy workflow, but further validation is needed in larger studies.
Introduction: An increasing shortage of donor blood is expected, considering the demographic change in Germany. Due to the short shelf life and varying daily fluctuations in consumption, the storage of platelet concentrates (PCs) becomes challenging. This emphasizes the need for reliable prediction of needed PCs for the blood bank inventories.
View Article and Find Full Text PDFThe aim of the study was to evaluate the impact of the newly developed Similar patient search (SPS) Web Service, which supports reading complex lung diseases in computed tomography (CT), on the diagnostic accuracy of residents. SPS is an image-based search engine for pre-diagnosed cases along with related clinical reference content ( https://eref.thieme.
View Article and Find Full Text PDFThe complex process of manual biomarker extraction from body composition analysis (BCA) has far restricted the analysis of SARS-CoV-2 outcomes to small patient cohorts and a limited number of tissue types. We investigate the association of two BCA-based biomarkers with the development of severe SARS-CoV-2 infections for 918 patients (354 female, 564 male) regarding disease severity and mortality (186 deceased). Multiple tissues, such as muscle, bone, or adipose tissue are used and acquired with a deep-learning-based, fully-automated BCA from computed tomography images of the chest.
View Article and Find Full Text PDFBackground: The aim of this study was to show that sequential intravenous and oral moxifloxacin monotherapy (400 mg once per day) is as efficacious and safe as a combination regimen (intravenous ceftriaxone, 2 g once per day, plus sequential intravenous and oral levofloxacin, 500 mg twice per day) in patients hospitalized with community-acquired pneumonia.
Methods: We conducted a prospective, multicenter, randomized, double-blind noninferiority trial. Patients with a Pneumonia Severity Index (PSI) of III-V were stratified on the basis of PSI risk class before randomization.